Versant Venture Management as of March 31, 2023
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 7 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| CRISPR Therapeutics Common Shares (CRSP) | 47.0 | $23M | 499k | 45.23 | |
| Gritstone Oncology Common Stock (GRTS) | 20.6 | $9.9M | 3.6M | 2.78 | |
| Passage Bio Common Stock (PASG) | 9.9 | $4.7M | 5.0M | 0.96 | |
| CymaBay Therapeutics Common Stock | 9.9 | $4.7M | 544k | 8.72 | |
| Adverum Biotechnologies Common Stock | 7.6 | $3.6M | 5.1M | 0.72 | |
| Aligos Therapeutics Common Stock (ALGS) | 4.2 | $2.0M | 2.3M | 0.87 | |
| Minerva Surgical Common Stock | 0.8 | $367k | 1.7M | 0.22 |
